TABLE I.
Baseline characteristics of the study population
| Characteristic | Patient group | ||
|---|---|---|---|
|
| |||
| CLL | iNHL | Overall | |
| Patients (n) | 16 | 74 | 90 |
| Age (years) | |||
| Mean±SD | 69.3±7.12 | 63.1±10.84 | 64.2±10.51 |
| Range | 55–85 | 40–90 | 40–90 |
| Age group [n (%)] | |||
| <70 Years | 9 (56.3) | 52 (70.3) | 61 (67.8) |
| ≥70 Years | 7 (43.8) | 22 (29.7) | 29 (32.2) |
| Sex [n (%)] | |||
| Women | 9 (56.3) | 35 (47.3) | 44 (48.9) |
| Men | 7 (43.8) | 39 (52.7) | 46 (51.1) |
| Race [n (%)] | |||
| White | 15 (93.8) | 66 (89.2) | 81 (90.0) |
| Black | 0 | 2 (2.7) | 2 (2.2) |
| Asian | 0 | 1 (1.4) | 1 (1.1) |
| Other | 1 (6.3) | 5 (6.8) | 6 (6.7) |
| ECOG PS [n (%)] | |||
| 0 | 9 (56.3) | 38 (51.4) | 47 (52.2) |
| 1 | 6 (37.5) | 30 (40.5) | 36 (40.0) |
| 2 | 1 (6.3) | 6 (8.1) | 7 (7.8) |
| Binet stage [n (%)] | |||
| B | 3 (18.8) | NA | 3 (18.8) |
| C | 2 (12.5) | NA | 2 (12.5) |
| Rai stage [n (%)] | |||
| II–IV | 11 (68.8) | NA | 11 (68.8) |
| iNHL type [n (%)] | |||
| Follicular | NA | 42 (56.8) | 42 (56.8) |
| Lymphoplasmacytic | NA | 12 (16.2) | 12 (16.2) |
| Marginal zone | NA | 10 (13.5) | 10 (13.5) |
| Small lymphocytic | NA | 10 (13.5) | 10 (13.5) |
CLL = chronic lymphocytic leukemia; iNHL = indolent non-Hodgkin lymphoma; SD = standard deviation; ECOG PS = Eastern Cooperative Oncology Group performance status; NA = not applicable.